End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
38,700
KRW
|
-4.21%
|
|
+7.65%
|
+107.06%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
351,928
|
327,118
|
563,048
|
244,901
|
339,052
|
Enterprise Value (EV)
1 |
319,512
|
294,504
|
542,153
|
286,515
|
479,696
|
P/E ratio
|
27.5
x
|
25.6
x
|
34.2
x
|
15.3
x
|
-45.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.69
x
|
4.17
x
|
5.01
x
|
2.21
x
|
3.6
x
|
EV / Revenue
|
5.17
x
|
3.76
x
|
4.82
x
|
2.58
x
|
5.1
x
|
EV / EBITDA
|
16.5
x
|
13.6
x
|
17.4
x
|
13.5
x
|
42.9
x
|
EV / FCF
|
-
|
-61,264,465
x
|
-30,021,291
x
|
-4,574,017
x
|
-13,357,894
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
2.42
x
|
2.07
x
|
3.25
x
|
1.3
x
|
1.92
x
|
Nbr of stocks (in thousands)
|
18,377
|
18,377
|
18,251
|
18,141
|
18,141
|
Reference price
2 |
19,150
|
17,800
|
30,850
|
13,500
|
18,690
|
Announcement Date
|
3/16/21
|
3/16/21
|
3/15/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
61,839
|
78,379
|
112,383
|
111,005
|
94,077
|
EBITDA
1 |
19,336
|
21,716
|
31,116
|
21,153
|
11,179
|
EBIT
1 |
13,430
|
14,047
|
21,979
|
9,261
|
-6,225
|
Operating Margin
|
21.72%
|
17.92%
|
19.56%
|
8.34%
|
-6.62%
|
Earnings before Tax (EBT)
1 |
13,374
|
14,187
|
19,148
|
12,603
|
-20,752
|
Net income
1 |
11,130
|
12,746
|
17,827
|
16,062
|
-7,399
|
Net margin
|
18%
|
16.26%
|
15.86%
|
14.47%
|
-7.86%
|
EPS
2 |
696.0
|
694.7
|
902.6
|
885.0
|
-408.0
|
Free Cash Flow
|
-
|
-4,807
|
-18,059
|
-62,640
|
-35,911
|
FCF margin
|
-
|
-6.13%
|
-16.07%
|
-56.43%
|
-38.17%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/16/21
|
3/16/21
|
3/15/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
30.35
|
25.5
|
28.84
|
29.58
|
23.06
|
29.52
|
23.56
|
27.13
|
20.78
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
6.03
|
3.93
|
3.048
|
3.635
|
1.131
|
1.447
|
-0.1021
|
0.9383
|
-2.851
|
Operating Margin
|
19.87%
|
15.41%
|
10.57%
|
12.29%
|
4.91%
|
4.9%
|
-0.43%
|
3.46%
|
-13.72%
|
Earnings before Tax (EBT)
1 |
6.295
|
0.049
|
2.627
|
8.258
|
2.118
|
-0.4002
|
-1.056
|
-1.789
|
-7.602
|
Net income
1 |
5.358
|
1.598
|
2.438
|
6.682
|
1.817
|
5.124
|
-
|
-
|
-6.05
|
Net margin
|
17.66%
|
6.27%
|
8.46%
|
22.59%
|
7.88%
|
17.36%
|
-
|
-
|
-29.11%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/10/21
|
3/8/22
|
5/16/22
|
8/12/22
|
11/14/22
|
3/16/23
|
5/15/23
|
8/14/23
|
11/14/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
41,614
|
140,644
|
Net Cash position
1 |
32,416
|
32,614
|
20,895
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
1.967
x
|
12.58
x
|
Free Cash Flow
|
-
|
-4,807
|
-18,059
|
-62,640
|
-35,911
|
ROE (net income / shareholders' equity)
|
-
|
8.33%
|
10.5%
|
8%
|
-9.95%
|
ROA (Net income/ Total Assets)
|
-
|
5.33%
|
6.62%
|
2.13%
|
-0.96%
|
Assets
1 |
-
|
239,046
|
269,152
|
753,228
|
772,888
|
Book Value Per Share
2 |
7,900
|
8,589
|
9,481
|
10,385
|
9,756
|
Cash Flow per Share
2 |
542.0
|
343.0
|
2,384
|
1,530
|
1,319
|
Capex
1 |
25,890
|
16,509
|
36,566
|
78,592
|
149,162
|
Capex / Sales
|
41.87%
|
21.06%
|
32.54%
|
70.8%
|
158.55%
|
Announcement Date
|
3/16/21
|
3/16/21
|
3/15/22
|
3/23/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| +107.06% | 540M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|